Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster optica - spectrum

Terms

4optica
6spectrum
4neuromyelitis
5disorders

Associations

Freq.WeightAssociation
44optica - spectrum
44neuromyelitis - spectrum
44neuromyelitis - optica
33disorders - spectrum
Documents par ordre de pertinence
000343 (2020) Edgar Carnero Contentti [Argentine] ; Jorge Correa [Argentine]Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge
000584 (2020) Itay Lotan [États-Unis] ; Richard Mcgowan [États-Unis] ; Michael Levy [États-Unis]Anti- IL-6 therapies for neuromyelitis optica spectrum disorders: A systematic review of safety and efficacy.
000121 (2020) Mattia Rosso [États-Unis] ; Shrishti Saxena [États-Unis] ; Tanuja Chitnis [États-Unis]Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options.
000165 (2020) Chao Zhang [République populaire de Chine] ; Meini Zhang [République populaire de Chine] ; Wei Qiu [République populaire de Chine] ; Hongshan Ma [République populaire de Chine] ; Xinghu Zhang [République populaire de Chine] ; Zilong Zhu [République populaire de Chine] ; Chun-Sheng Yang [République populaire de Chine] ; Dongmei Jia [République populaire de Chine] ; Tian-Xiang Zhang [République populaire de Chine] ; Meng Yuan [République populaire de Chine] ; Yan Feng [République populaire de Chine] ; Li Yang [République populaire de Chine] ; Wenli Lu [République populaire de Chine] ; Chunshui Yu [République populaire de Chine] ; Jeffrey L. Bennett [États-Unis] ; Fu-Dong Shi [République populaire de Chine]Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.
000146 (2020) Francis F. Furia [Tanzanie] ; Evance Godfrey [Tanzanie] ; Naomi Mwamanenge [Tanzanie] ; Peter Swai [Tanzanie]Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania
000038 (2020) Maria C. Cid [Espagne] ; Roberto Ríos-Garcés [Espagne] ; Nekane Terrades-García [Espagne] ; Georgina Espígol-Frigolé [Espagne]Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies.
000312 (2020) Clara Camaschella [Italie] ; Antonella Nai [Italie] ; Laura Silvestri [Italie]Iron metabolism and iron disorders revisited in the hepcidin era
000502 (2020) Kazuhisa Nakano [Japon] ; Kazuyoshi Saito [Japon] ; Aya Nawata [Japon] ; Kentaro Hanami [Japon] ; Satoshi Kubo [Japon] ; Ippei Miyagawa [Japon] ; Yoshihisa Fujino [Japon] ; Shingo Nakayamada [Japon] ; Yoshiya Tanaka [Japon]Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021